These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
524 related items for PubMed ID: 18262313
1. A recombinant pseudorabies virus expressing rabies virus glycoprotein: safety and immunogenicity in dogs. Yuan Z, Zhang S, Liu Y, Zhang F, Fooks AR, Li Q, Hu R. Vaccine; 2008 Mar 04; 26(10):1314-21. PubMed ID: 18262313 [Abstract] [Full Text] [Related]
2. Immunogenicity and protective efficacy of recombinant pseudorabies virus expressing the two major membrane-associated proteins of porcine reproductive and respiratory syndrome virus. Jiang Y, Fang L, Xiao S, Zhang H, Pan Y, Luo R, Li B, Chen H. Vaccine; 2007 Jan 05; 25(3):547-60. PubMed ID: 16920232 [Abstract] [Full Text] [Related]
3. Immunogenicity of a recombinant pseudorabies virus expressing ORF1-ORF2 fusion protein of porcine circovirus type 2. Ju C, Fan H, Tan Y, Liu Z, Xi X, Cao S, Wu B, Chen H. Vet Microbiol; 2005 Aug 30; 109(3-4):179-90. PubMed ID: 16006077 [Abstract] [Full Text] [Related]
4. A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice. Li J, Faber M, Papaneri A, Faber ML, McGettigan JP, Schnell MJ, Dietzschold B. Virology; 2005 Aug 30; 356(1-2):147-54. PubMed ID: 16938327 [Abstract] [Full Text] [Related]
5. Vaccine-induced T cell-mediated immunity plays a critical role in early protection against pseudorabies virus (suid herpes virus type 1) infection in pigs. van Rooij EM, de Bruin MG, de Visser YE, Middel WG, Boersma WJ, Bianchi AT. Vet Immunol Immunopathol; 2004 May 30; 99(1-2):113-25. PubMed ID: 15113659 [Abstract] [Full Text] [Related]
9. Field trial to evaluate the immunogenicity of pseudorabies virus vaccines with deletions for glycoproteins G and E. Firkins LD, Weigel RM, Biehl LG, Hahn EC. Am J Vet Res; 1997 Sep 30; 58(9):976-84. PubMed ID: 9285001 [Abstract] [Full Text] [Related]
10. Recombinant canine distemper virus serves as bivalent live vaccine against rabies and canine distemper. Wang X, Feng N, Ge J, Shuai L, Peng L, Gao Y, Yang S, Xia X, Bu Z. Vaccine; 2012 Jul 20; 30(34):5067-72. PubMed ID: 22698451 [Abstract] [Full Text] [Related]
12. Antibody response to glycoprotein I in maternally immune pigs exposed to a mildly virulent strain of pseudorabies virus. van Oirschot JT, Daus F, Kimman TG, van Zaane D. Am J Vet Res; 1991 Nov 20; 52(11):1788-93. PubMed ID: 1664670 [Abstract] [Full Text] [Related]
14. A DNA vaccine coding for gB and gD of pseudorabies virus (suid herpes type 1) primes the immune system in the presence of maternal immunity more efficiently than conventional vaccines. van Rooij EM, Moonen-Leusen HW, de Visser YE, Middel WG, Boersma WJ, Bianchi AT. Vaccine; 2006 Feb 27; 24(9):1264-73. PubMed ID: 16289276 [Abstract] [Full Text] [Related]
16. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus. Li X, Liu R, Tang H, Jin M, Chen H, Qian P. Vaccine; 2008 May 23; 26(22):2714-22. PubMed ID: 18436351 [Abstract] [Full Text] [Related]
17. Comparison of different prime-boost regimes with DNA and recombinant Orf virus based vaccines expressing glycoprotein D of pseudorabies virus in pigs. van Rooij EM, Rijsewijk FA, Moonen-Leusen HW, Bianchi AT, Rziha HJ. Vaccine; 2010 Feb 17; 28(7):1808-13. PubMed ID: 20018271 [Abstract] [Full Text] [Related]
18. Generation and evaluation of a recombinant modified vaccinia virus Ankara vaccine for rabies. Weyer J, Rupprecht CE, Mans J, Viljoen GJ, Nel LH. Vaccine; 2007 May 22; 25(21):4213-22. PubMed ID: 17434244 [Abstract] [Full Text] [Related]